In vitro schedule-dependent interaction between paclitaxel and oxaliplatin in human cancer cell lines

被引：0
|
作者：
Risa Tanaka
Hiroshi Ariyama
Baoli Qin
Yasushi Takii
Eishi Baba
Kenji Mitsugi
Mine Harada
Shuji Nakano
机构：
[1] Kyushu University,First Department of Internal Medicine and Department of Biosystemic Science of Medicine, Graduate School of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2005年 / 55卷
关键词：
Oxaliplatin; Paclitaxel; Drug interaction; Sequence-dependence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：595 / 601
页数：6
相关论文
共 50 条
  • [1] In vitro schedule-dependent interaction between paclitaxel and oxaliplatin in human cancer cell lines
    Tanaka, R
    Ariyama, H
    Qin, BL
    Takii, Y
    Baba, E
    Mitsugi, K
    Harada, M
    Nakano, S
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (06) : 595 - 601
  • [2] Schedule-dependent interaction between paclitaxel and doxorubicin in human cancer cell lines in vitro
    Akutsu, M
    Kano, Y
    Tsunoda, S
    Suzuki, K
    Yazawa, Y
    Miura, Y
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (13-14) : 2341 - 2346
  • [3] In Vitro Schedule-Dependent Interaction Between Melphalan and Oxaliplatin in Human Colorectal Cancer Cell Lines
    van Iersel, Liselot B. J.
    Koudijs, Tamara M.
    Hoekman, Ellen J.
    Janssen-van Rhijn, Connie M.
    Vahrmeijer, Alexander L.
    Nortier, Johan W. R.
    van de Velde, Cornelis J. H.
    Gelderblom, Hans
    Kuppen, Peter J. K.
    JOURNAL OF SURGICAL RESEARCH, 2011, 167 (02) : 273 - 278
  • [4] In vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell lines
    Qin, B.
    Tanaka, R.
    Shibata, Y.
    Arita, S.
    Ariyama, H.
    Kusaba, H.
    Babe, E.
    Harada, M.
    Nakano, S.
    ANNALS OF ONCOLOGY, 2006, 17 : 52 - 52
  • [5] In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell lines
    Qin, Baoli
    Tanaka, Risa
    Shibata, Yoshihiro
    Arita, Shuji
    Ariyama, Hiroshi
    Kusaba, Hitoshi
    Baba, Eishi
    Harada, Mine
    Nakano, Shuji
    ANTI-CANCER DRUGS, 2006, 17 (04) : 445 - 453
  • [6] Schedule-dependent interaction between paclitaxel and 5-fluorouracil in human carcinoma cell lines in vitro
    Kano, Y
    Akutsu, M
    Tsunoda, S
    Ando, J
    Matsui, J
    Suzuki, K
    Ikeda, T
    Inoue, Y
    Adachi, KI
    BRITISH JOURNAL OF CANCER, 1996, 74 (05) : 704 - 710
  • [7] Schedule-dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines
    Zoli, W
    Ricotti, L
    Barzanti, F
    Dal Susino, M
    Frassineti, GL
    Milandri, C
    Giunchi, DC
    Amadori, D
    INTERNATIONAL JOURNAL OF CANCER, 1999, 80 (03) : 413 - 416
  • [8] Schedule-dependent interactions between paclitaxel and etoposide in human carcinoma cell lines in vitro
    Kano, Y
    Akutsu, M
    Suzuki, K
    Mori, K
    Yazawa, Y
    Tsunoda, S
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (05) : 381 - 388
  • [9] Schedule-dependent interactions between paclitaxel and etoposide in human carcinoma cell lines in vitro
    Yasuhiko Kano
    Miyuki Akutsu
    Kenichi Suzuki
    Kiyoshi Mori
    Yasuo Yazawa
    Saburo Tsunoda
    Cancer Chemotherapy and Pharmacology, 1999, 44 : 381 - 388
  • [10] Schedule-dependent interactions between vinorelbine and paclitaxel in human carcinoma cell lines in vitro
    Kano, Y
    Akutsu, M
    Suzuki, K
    Ando, J
    Tsunoda, S
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 56 (01) : 79 - 90
12345